Procedure guideline for extended scintigraphy for differentiated thyroid cancer: 1.0

Journal of Nuclear Medicine

Volumn 37, Issue 7, 1996, Pages 1269-1271

  Becker, David ^b   Charkes, N David ^b   Dworkin, Howard ^b   Hurley, James ^b   McDougall, I Ross ^b   Price, David ^b   Royal, Henry ^b   Sarkar, Salil ^b   Smith, Wendy ^a  

^a Society of Nuclear Medicine   (United States)

^b NONE

Author keywords

differentiated thyroid cancer; procedure guideline

Indexed keywords

IODINE 123; IODINE 131; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; THALLIUM 201;

ADULT; CANCER DIAGNOSIS; COST EFFECTIVENESS ANALYSIS; DOSIMETRY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; SCINTIGRAPHY; SHORT SURVEY; THYROID CANCER; THYROID DISEASE; THYROID SCINTISCANNING;

ADULT; HUMANS; IODINE RADIOISOTOPES; RADIATION DOSAGE; SOCIETIES, MEDICAL; THYROID NEOPLASMS; UNITED STATES;

EID: 0029740692     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (5)

1. 131I ablation of thyroid remnants. Clin Nucl Med 1983;8:123-126.
2. Maxon HR, Thomas SR, Hertzberg VS, et al. Relation between effective radiation dose and outcome of radioiodine therapy of thyroid cancer. N Engl J Med 1983; 309:937-941.
3. Ramanna L, Waxman AD, Braunstein G. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations. J Nucl Med 1991;32:441-446.
4. Sherman SI, Tielens ET, Sostre S, et al. Clinical utility of post-treatment radioiodine scans in the management of patients with thyroid carcinoma. J Clin Endocrinol Metab 1994;78:629-634.
5. Yen TC, Lin HD, Lee CH, et al. The role of technetium-99m-sestamibi whole-body scans in diagnosing metastatic Hurthle cell carcinoma of the thyroid gland after total thyroidectomy: a comparison with iodine-131 and thallium-201 whole-body scans. Eur J Nucl Med 1994; 21:980-983.